{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": 2020
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Parkinsonâ€™s disease (PD) is a movement disorder caused by degeneration of dopaminergic neurons. Leucine-rich repeat kinase 2 (LRRK2) is the gene responsible for autosomal dominant PD, PARK8.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the degeneration of dopaminergic neurons caused by mutations in the LRRK2 gene."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study investigates the intracellular degradation rate and the protective effect against apoptosis of the I2020T mutant LRRK2 compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The assays used (intracellular degradation and apoptosis protection) effectively model the disease pathogenesis, which involves neurodegeneration and apoptosis."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "sub_steps": [
            {
              "step_name": "Sub-step 3a: Basic Controls and Replicates",
              "extracted_paper_info": "The study includes both wild-type LRRK2 and I2020T mutant LRRK2 as controls and uses multiple replicates for the experiments.",
              "judgment": "Yes",
              "reasoning": "Both 'Normal/Negative/Wild type' and 'Abnormal/Positive/Null' controls were used, and the experiments were performed in triplicate."
            },
            {
              "step_name": "Sub-step 3c: Variant Controls",
              "extracted_paper_info": "The study compares the I2020T mutant LRRK2 with wild-type LRRK2 and other mutants like G2019S.",
              "judgment": "Yes",
              "reasoning": "Known pathogenic variants (like G2019S) were used as controls, enhancing the validity of the functional evidence."
            }
          ]
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_steps": [
            {
              "step_name": "Sub-step 4b: No OddsPath Calculation",
              "extracted_paper_info": "The study does not provide a direct OddsPath calculation but uses multiple benign and pathogenic variant controls.",
              "judgment": "At least 11",
              "reasoning": "The study uses multiple controls, including wild-type and several mutants, providing sufficient data points."
            }
          ]
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The I2020T variant in LRRK2 shows increased intracellular degradation and impaired protectivity against apoptosis compared to wild-type LRRK2. The functional assays used are well-controlled and validated, supporting the pathogenic nature of this variant."
    }
  ]
}